We are live on
!
Find out more
LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$6.2B
1-Year Est. Return
38.92%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$10.8B
AUM Growth
-$173M
(-1.6%)
Cap. Flow
-$272M
Cap. Flow
% of AUM
-2.53%
Top 10 Holdings %
Top 10 Hldgs %
36.63%
Holding
103
New
4
Increased
19
Reduced
65
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$43M |
| 2 |
PVG
PRETIUM RESOURCES INC.
PVG
|
+$35.4M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$26.3M |
| 4 |
Skyworks Solutions
SWKS
|
+$23.4M |
| 5 |
Hudbay
HBM
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$72.8M |
| 2 |
Merck
MRK
|
+$52.9M |
| 3 |
Thomson Reuters
TRI
|
+$44.9M |
| 4 |
Suncor Energy
SU
|
+$37.2M |
| 5 |
Pfizer
PFE
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.41% |
| 2 | Energy | 20.76% |
| 3 | Communication Services | 14.31% |
| 4 | Technology | 8.6% |
| 5 | Materials | 7.81% |
Similar funds
NP
WIA
EIP
B
CA
ACM
AWA
DTC
Letko, Brosseau & Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Letko, Brosseau & Associates held 103 positions worth $10.8B, down 1.6% from $10.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Letko, Brosseau & Associates's Q3 2018 filing shows 4 new, 19 increased, 65 reduced and 2 closed positions. Its largest new stake was Meta Platforms (Facebook): 237,622 shares worth $39.1M. The largest sale was LifePoint Health, Inc., an estimated $72.8M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Communication Services.
- Letko, Brosseau & Associates's largest Q3 2018 buy was Meta Platforms (Facebook): 237,622 shares worth $39.1M.
- Letko, Brosseau & Associates added most to PRETIUM RESOURCES INC. in Q3 2018, an estimated $35.4M increase.
- Letko, Brosseau & Associates's biggest Q3 2018 reduction was Merck, cutting an estimated $52.9M.
- Letko, Brosseau & Associates fully exited LifePoint Health, Inc. in Q3 2018, selling an estimated $72.8M.
- Letko, Brosseau & Associates's ten largest holdings make up 37% of its $10.8B portfolio in Q3 2018.
- Letko, Brosseau & Associates opened 4 new positions and closed 2 in Q3 2018.
- Letko, Brosseau & Associates's portfolio value fell 1.6% quarter-over-quarter to $10.8B.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2018, filed 8 Nov 2018.